Do NPM1 and FLT3-ITD mutations modify prognosis in patients treated with non-intensive regimens?

  1. Suárez, E.U.
  2. Boluda, B.
  3. Lavilla, E.
  4. Tormo, M.
  5. Botella, C.
  6. Gil, C.
  7. Vives, S.
  8. Rodríguez, C.
  9. Serrano, J.
  10. Sayas, M.J.
  11. Martínez-Sánchez, P.
  12. Ramos, F.
  13. Bernal, T.
  14. Algarra, L.
  15. Bergua-Burgues, J.M.
  16. Pérez-Simón, J.A.
  17. Herrera, P.
  18. Barrios, M.
  19. Noriega-Concepción, V.
  20. Raposo-Puglia, J.A.
  21. Ayala, R.
  22. Barragán, E.
  23. Martínez-Cuadrón, D.
  24. Amigo, M.L.
  25. López-Lorenzo, J.L.
  26. Lázaro-García, A.
  27. Guimaraes, J.E.
  28. Colorado, M.
  29. García-Boyero, R.
  30. De Rueda-Ciller, B.
  31. Foncillas-García, M.
  32. Hong, A.
  33. Labrador, J.
  34. Alonso-Dominguez, J.M.
  35. Montesinos, P.
  36. Show all authors +
Journal:
Annals of Hematology

ISSN: 1432-0584 0939-5555

Year of publication: 2024

Volume: 103

Issue: 8

Pages: 2845-2851

Type: Article

DOI: 10.1007/S00277-024-05840-7 GOOGLE SCHOLAR